AMA submission on TGA proposals for enhancing medicines monitoring activities

The AMA supports a comprehensive product vigilance system in line with international best practice, and the development of proactive strategies that enhance the robustness of post market surveillance. The AMA therefore fully supports the TGA's proposals to enhance post-market monitoring of medicines in Australia.